APA aipamena

Noël, C., Abramowicz, D., Durand, D., Mourad, G., Lang, P., Kessler, M., . . . Hazzan, M. (2009). Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients. American Society of Nephrology.

Chicago Style aipamena

Noël, Christian, et al. Daclizumab Versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients. American Society of Nephrology, 2009.

MLA aipamena

Noël, Christian, et al. Daclizumab Versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients. American Society of Nephrology, 2009.